⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

CRL

Charles River Laboratories International, Inc.

Healthcare · Diagnostics & Research

345.37USD

+5.7100 (+1.68%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on CRL.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$2.97▼$3.0542
Next quarter$3.33▲$3.2431
Current year$11.38▲$11.153
Next year$12.75▲$12.3363

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$2.74$3.02+0.28 (+10.3%)
2026-03-31$1.95$2.06+0.11 (+5.4%)
2025-12-31$2.35$2.39+0.04 (+1.9%)
2025-09-30$2.34$2.43+0.09 (+3.9%)

Wall Street coverage

276 ratings from 34 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Morgan StanleyMaintainedOverweight$300 $340Oct 13, 2026
JefferiesMaintainedBuy$305 $340Sep 28, 2026
Deutsche BankMaintainedBuy$300 $320Sep 25, 2026
TD CowenMaintainedBuy$300 $325Sep 25, 2026
Evercore ISI GroupMaintainedOutperform$320 $330Sep 25, 2026
RBC CapitalMaintainedOutperform$282 $322Sep 25, 2026
BarclaysMaintainedOverweight$300 $330Sep 25, 2026
MizuhoMaintainedNeutral$264 $295Sep 25, 2026
BairdMaintainedOutperform$291 $334Sep 25, 2026
Evercore ISI GroupMaintainedOutperform$300 $320Sep 11, 2026
TD CowenMaintainedBuy$235 $300Aug 10, 2026
Morgan StanleyMaintainedOverweight$260 $300Aug 7, 2026
RBC CapitalMaintainedOutperform$215 $282Aug 6, 2026
Evercore ISI GroupMaintainedOutperform$260 $300Aug 6, 2026
JP MorganUpgraded from NeutralOverweight$180 $310Aug 6, 2026
CLSADowngraded from OutperformHold$219Jul 20, 2026
MizuhoMaintainedNeutral$192 $230Jul 13, 2026
Morgan StanleyMaintainedOverweight$220 $260Jul 9, 2026
Morgan StanleyUpgraded from Equal-WeightOverweight$185 $220Jun 17, 2026
CLSAUpgraded from HoldOutperform$167 $219May 29, 2026
BarclaysMaintainedOverweight$210 $220May 8, 2026
Evercore ISI GroupMaintainedOutperform$200 $220May 8, 2026
BarclaysMaintainedOverweight$200 $210Apr 14, 2026
JP MorganMaintainedNeutral$165 $160Apr 13, 2026
UBSMaintainedNeutral$170 $175Feb 25, 2026

Insider transactions

102 filings from 24 insiders · 36 buy / 11 sell over 6m

Officers and directors of CRL, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Parisotto Shannon MOfficer, CEVP, Disc & Safety AssessmentExerciseStock Options (Right to Buy)2.2k——Oct 21, 2026
Parisotto Shannon MOfficer, CEVP, Disc & Safety AssessmentSell2.2k$344.41$743kOct 21, 2026
Parisotto Shannon MOfficer, CEVP, Disc & Safety AssessmentExercise2.2k$244.41$527kOct 21, 2026
Parisotto Shannon MOfficer, CEVP, Disc & Safety AssessmentExerciseStock Options (Right to Buy)981——Oct 5, 2026
Parisotto Shannon MOfficer, CEVP, Disc & Safety AssessmentSell981$308.44$303kOct 5, 2026
Parisotto Shannon MOfficer, CEVP, Disc & Safety AssessmentExercise981$208.44$204kOct 5, 2026
Coleman GlennOfficer, EVP & Chief Financial OfficerBuy10$297.43$3kSep 30, 2026
FOSTER JAMES CDirectorExercise33.6k$194.12$6.69MAug 25, 2026
FOSTER JAMES CDirectorSell33.6k$300.00$10.07MAug 25, 2026
PARISOTTO SHANNON MOfficerExercise2.0k$194.12$396kAug 19, 2026
PARISOTTO SHANNON MOfficerSell2.0k$294.12$600kAug 19, 2026
GIRSHICK BIRGITChief Executive OfficerGift528——Aug 19, 2026
ANDREWS NANCY CDirectorExercise573$164.30$94kAug 18, 2026
ANDREWS NANCY CDirectorSell573$285.24$163kAug 18, 2026
PARISOTTO SHANNON MOfficerSell3.7k$279.66$1.04MAug 11, 2026
GIRSHICK BIRGITChief Executive OfficerSell6.5k$279.90$1.82MAug 11, 2026
GIRSHICK BIRGITChief Executive OfficerExercise6.5k$179.66$1.17MAug 11, 2026
PARISOTTO SHANNON MOfficerExercise3.7k$179.66$667kAug 11, 2026
LAPLUME JOSEPH WOfficerGift257——Aug 10, 2026
FOSTER JAMES CDirectorSell28.7k$275.00$7.90MAug 10, 2026

Analyst Notes

Sign in to write

No analyst notes on CRL yet.

Top voices on CRL

Members whose judged calls on CRL have played out most reliably.

No settled calls on CRL yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice

Analyst Ratings

15 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current311210Buy2.06
1 mo ago411210Buy2.00
2 mo ago49210Buy2.00
3 mo ago39310Buy2.13
Price target$314.20$145.00 – $357.00
-9.0% to target